Anderson Kenneth Carl
Insider CIK 1824862 · CCCC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics, Inc. | A Award | 2026-10-01 | 2026-10-02 | 3,662 | $3.14 | $11.5K | 75,612 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2026-07-01 | 2026-07-02 | 2,650 | $4.34 | $11.5K | 71,950 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 62,000 | — | $0 | 62,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2026-06-01 | 2026-06-04 | 1,070 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2026-06-01 | 2026-06-04 | 1,070 | $2.11 | $2.3K | 69,300 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2026-04-01 | 2026-04-03 | 4,259 | $2.70 | $11.5K | 68,230 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 5,958 | $1.93 | $11.5K | 146,532 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-10-01 | 2025-10-03 | 5,349 | $2.15 | $11.5K | 140,574 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-07-01 | 2025-07-02 | 7,616 | $1.51 | $11.5K | 135,225 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 35,500 | — | $0 | 35,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-04-01 | 2025-04-03 | 7,841 | $1.44 | $11.3K | 127,609 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-01-02 | 2025-01-03 | 3,074 | $3.66 | $11.3K | 119,768 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-10-01 | 2024-10-02 | 2,023 | $5.56 | $11.2K | 116,694 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-07-01 | 2024-07-02 | 2,320 | $4.85 | $11.3K | 114,671 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 32,500 | — | $0 | 32,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-04-01 | 2024-04-02 | 1,389 | $8.10 | $11.3K | 112,351 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-01-02 | 2024-01-03 | 1,725 | $6.52 | $11.2K | 110,962 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-10-02 | 2023-10-03 | 6,617 | $1.70 | $11.2K | 109,237 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-07-03 | 2023-07-05 | 3,976 | $2.83 | $11.3K | 102,620 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-04-03 | 2023-04-04 | 3,516 | $3.20 | $11.3K | 98,644 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-06 | 2023-01-06 | 444 | — | $0 | 890 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-06 | 2023-01-06 | 268 | — | $0 | 1,067 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-06 | 2023-01-06 | 444 | $4.98 | $2.2K | 95,128 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-06 | 2023-01-06 | 268 | $2.11 | $565 | 94,684 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-04 | 1,568 | $6.38 | $10.0K | 94,416 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-10-03 | 2022-10-04 | 445 | — | $0 | 1,334 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-10-03 | 2022-10-04 | 267 | — | $0 | 1,335 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-10-03 | 2022-10-04 | 267 | $2.11 | $563 | 91,253 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-10-03 | 2022-10-04 | 445 | $4.98 | $2.2K | 91,698 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2022-10-03 | 2022-10-04 | 1,150 | $8.69 | $10.0K | 92,848 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-07-15 | 2022-07-18 | 535 | — | $0 | 1,602 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-07-15 | 2022-07-18 | 889 | — | $0 | 1,779 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-07-15 | 2022-07-18 | 889 | $4.98 | $4.4K | 90,986 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-07-15 | 2022-07-18 | 535 | $2.11 | $1.1K | 90,097 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2022-07-01 | 2022-07-05 | 1,246 | $8.03 | $10.0K | 89,562 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-23 | 23,500 | — | $0 | 23,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2022-04-04 | 2022-04-05 | 341 | $26.46 | $9.0K | 88,316 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-01-26 | 2022-01-26 | 1,334 | — | $0 | 2,668 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-01-26 | 2022-01-26 | 803 | — | $0 | 2,137 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-01-26 | 2022-01-26 | 1,334 | $4.98 | $6.6K | 87,975 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-01-26 | 2022-01-26 | 803 | $2.11 | $1.7K | 86,641 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2022-01-04 | 2022-01-18 | 278 | $31.58 | $8.8K | 85,838 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2021-10-04 | 2021-10-05 | 194 | $44.99 | $8.7K | 85,560 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2021-07-02 | 2021-07-07 | 220 | $39.72 | $8.7K | 85,366 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2021-06-15 | 2021-06-17 | 23,500 | — | $0 | 23,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-04-14 | 2021-04-14 | 267 | — | $0 | 2,940 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-04-14 | 2021-04-14 | 444 | — | $0 | 4,002 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-04-14 | 2021-04-14 | 267 | $2.11 | $563 | 84,702 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-04-14 | 2021-04-14 | 444 | $4.98 | $2.2K | 85,146 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | G Gift | 2021-04-13 | 2021-04-14 | 2,278 | — | $0 | 84,435 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | G Gift | 2021-04-13 | 2021-04-14 | 2,278 | — | $0 | 47,316 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2021-04-05 | 2021-04-06 | 233 | $37.51 | $8.7K | 82,157 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-01-22 | 2021-01-26 | 538 | — | $0 | 3,207 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-01-22 | 2021-01-26 | 889 | — | $0 | 4,446 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-01-22 | 2021-01-26 | 121 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-01-22 | 2021-01-26 | 538 | $2.11 | $1.1K | 80,914 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-01-22 | 2021-01-26 | 889 | $4.98 | $4.4K | 81,924 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-01-22 | 2021-01-26 | 121 | $2.11 | $255 | 81,035 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 152,160 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 142,857 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 347,840 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 152,160 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 142,857 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-06 | 347,840 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 18,040 | — | $0 | 80,376 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 18,040 | — | $0 | 45,038 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 41,244 | — | $0 | 63,543 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 16,939 | — | $0 | 16,939 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 16,939 | — | $0 | 16,939 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | C Conversion | 2020-10-06 | 2020-10-06 | 41,244 | — | $0 | 63,543 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 17,786 | — | $0 | 17,786 | SEC↗ |